Digital PCR Quantification Using Non-Specific DNA-Binding Dyes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current digital PCR methods face scalability issues in synthesizing and optimizing fluorescent oligonucleotide probes for large numbers of genes, limiting their effectiveness in digital copy number analysis, and require new strategies for multiplexing without spectral context.

Innovation Solution

The use of non-specific DNA-binding dyes like EvaGreen, combined with mutant-specific and wild-type-specific primers having non-complementary 'tail' sequences of different lengths, allows for discrimination and quantification of amplicons based on length differences, enabling the detection of rare genetic events and copy number variations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If fluorescent oligonucleotide probes are used for digital PCR detection, then detection specificity is improved, but scalability and ease of manufacture deteriorate due to synthesis and optimization complexity for large numbers of genes

Engineering Contradiction:
Improvedetection specificityVSAvoidscalability
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent extracts the detection function from sequence-specific fluorescent probes and relocates it to a universal DNA-binding dye system. By using dyes like EvaGreen that bind non-specifically to dsDNA, the invention eliminates the need to synthesize and optimize multiple fluorescent probes for different genes, thereby improving scalability while maintaining detection capability through amplicon length differentiation

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent implements universality by employing a single type of non-specific DNA-binding dye that can detect all amplified products regardless of sequence. This universal dye system replaces the need for multiple gene-specific fluorescent probes, enabling simultaneous detection of multiple genes using the same reagent system and significantly improving manufacturing scalability

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If multiple spectrally distinct fluorophores are used for detecting different targets, then detection capability for multiple genes is improved, but device complexity and ease of operation worsen due to spectral multiplexing requirements

Engineering Contradiction:
Improvedetection capability for multiple genesVSAvoidspectral multiplexing requirements
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by differentiating amplicons based on their physical length rather than using multiple fluorescent signals. By creating amplicons of distinct lengths through primer design (with different tail lengths for different genes), the system segments the detection problem into spatial/physical dimensions that can be resolved by a single dye, eliminating spectral multiplexing complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from spectral dimension (multiple fluorophores with different wavelengths) to a physical dimension (amplicon length). This dimensional change allows multiple genes to be detected using a single fluorescent dye, as the differentiation is based on the size of the amplified product rather than the color of the signal, thereby reducing device complexity

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Illumination intensity

If DNA binding dyes are used at high concentrations to maintain resolution, then signal intensity is improved, but PCR inhibition increases

Engineering Contradiction:
Improvesignal intensityVSAvoidPCR inhibition
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the concentration parameter of the DNA-binding dye to an optimal level that balances signal intensity with PCR compatibility. By carefully controlling the dye concentration (using dyes like EvaGreen that bind dsDNA with high affinity but maintain PCR compatibility at moderate concentrations), the system achieves sufficient signal for detection without causing polymerase inhibition, thereby resolving the contradiction between signal intensity and PCR effectiveness

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables efficient detection and quantification of mutant alleles, single nucleotide mutations, and copy number variations, even in low-concentration samples, by utilizing a single-color digital PCR system that distinguishes amplicons based on fluorescence intensity, improving scalability and sensitivity.

Implementation Method 1

a fluorescent DNA dye. The fluorescent DNA dye can be any dye that binds nonspecifically to DNA (i.e. binds DNA of any sequence) that will allow discrimination of amplicons by length and quantitative measurement of target nucleic acids

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

The EG fluorophore is a non-specific double-stranded DNA (dsDNA) binding dye. When no DNA is present, EG assumes an inactive configuration, emitting a fluorescent signal only when template is bound

Methodology Applied
Scientific EffectDNA binding: Absorption (physical)

Data Source

PatentUS10465238B2Quantification of mutant alleles and copy number variation using digital PCR with nonspecific DNA-binding dyes
Publication Date: 2019.11.05 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US10465238B2 patent drawing
  • US10465238B2 patent drawing
  • US10465238B2 patent drawing

AI summary

Methods and reagents for performing digital PCR for detection and quantification of mutant alleles and copy number variation are disclosed. In particular, the invention relates to methods using a nonspecific DNA-binding dye, which produces a fluorescent signal that increases in intensity according to the number of base-pairs present in the PCR amplicon product. The method utilizes mutant-specific and wild-type-specific primers having non-complementary “tail” sequences of different lengths. Accordingly, the amplicons for the wild-type and mutant alleles differ in length and can be distinguished based on the difference in the intensities of their fluorescent signals. The methods of the invention can be used to detect rare genetic events, including single nucleotide mutations, alterations of copy number, and deletions or insertions of nucleotides.